This trial is active, not recruiting.

Condition plantar fasciitis
Treatment surgical proximal medial gastrocnemius recession
Sponsor Oslo University Hospital
Start date August 2014
End date January 2017
Trial size 40 participants
Trial identifier NCT02116478, 2013/2055


The purpose of the study is to compare the clinical results for patients suffering from plantar fasciitis treated with gastrocnemius recession vs. conservative treatment.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Endpoint classification efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
gastrocnemius recession
surgical proximal medial gastrocnemius recession
proximal medial gastrocnemius recession

Primary Outcomes

0-100 points scale, American Orthopaedic foot and ankle society (AOFAS) ankle-hindfoot score
time frame: 1 year postoperative

Secondary Outcomes

0-10 points Visual analog pain score
time frame: 1 year postoperative

Eligibility Criteria

Male or female participants from 18 years up to 70 years old.

Inclusion Criteria: - Symptoms of plantar fasciitis lasting more than 12 months. - Isolated gastrocnemius contracture Exclusion Criteria: - No previous surgery to foot or ankle - No active arthritis

Additional Information

Official title Gastrocnemius Recession vs. Conservative Treatment for Chronic Plantar Fasciitis. A Randomized Controlled Trial.
Principal investigator Marius Molund, MD
Description All patients will be instructed in stretching exercises. Half of the patients will be randomized to proximal medial gastrocnemius recession. All patients will be followed for 1 year.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Oslo University Hospital.